Publikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (4)

2017

  1. Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts

    British Journal of Dermatology, Vol. 176, Núm. 3, pp. 643-649

2015

  1. A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881

  2. Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis

    Pharmacogenomics Journal, Vol. 15, Núm. 4, pp. 322-325

2011

  1. Diseño y validación de un cuestionario para medir la satisfacción con el tratamiento del paciente con psoriasis moderada y grave: Estudio NEODERMA

    Actas Dermo-Sifiliograficas, Vol. 102, Núm. 1, pp. 28-38